Kenji Ishii Selected Research

Glioma (Gliomas)

5/2019	Usefulness of [11C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma.
7/2009	PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
6/2009	Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.
9/2005	Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Ishii Research Topics

Disease

37	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 11/2007
14	Cognitive Dysfunction 01/2022 - 07/2010
14	Dementia (Dementias) 10/2020 - 11/2007
11	Parkinson Disease (Parkinson's Disease) 07/2022 - 12/2002
10	Neoplasms (Cancer) 07/2021 - 01/2004
7	Gliosis 07/2022 - 12/2017
5	Atrophy 01/2022 - 03/2010
4	Glioma (Gliomas) 05/2019 - 09/2005
4	Amyloid Plaque 06/2016 - 08/2012
3	Cerebral Infarction 01/2021 - 12/2017
3	Multiple Sclerosis 01/2021 - 05/2019
3	Stroke (Strokes) 01/2020 - 03/2003
3	Benign essential blepharospasm 01/2019 - 07/2007
3	Tauopathies 01/2019 - 11/2007
3	Insulin Resistance 01/2017 - 08/2015
3	Parkinsonian Disorders (Parkinsonism) 05/2016 - 01/2013
3	Hemianopsia (Bitemporal Hemianopsia) 01/2016 - 01/2003
3	Multiple System Atrophy 09/2015 - 01/2008
3	Inflammation (Inflammations) 02/2013 - 08/2003
2	Nervous System Diseases (Neurological Disorders) 07/2022 - 01/2021
2	Brain Neoplasms (Brain Tumor) 03/2022 - 11/2014
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2021
2	Progressive Multifocal Leukoencephalopathy 01/2021 - 01/2017
2	Pain (Aches) 09/2020 - 04/2014
2	Infarction (Infarctions) 01/2020 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 05/2018
2	Astrocytoma (Pilocytic Astrocytoma) 05/2019 - 06/2009
2	Diffuse Axonal Injury 01/2018 - 01/2013
2	Cerebellar Ataxia (Dysmetria) 04/2017 - 11/2016
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 11/2016 - 08/2015
2	Glaucoma 11/2015 - 05/2013
2	Disease Progression 09/2015 - 04/2014
2	Diabetes Mellitus 02/2015 - 04/2008
2	Blepharospasm 01/2011 - 07/2003
2	Mental Disorders (Mental Disorder) 10/2007 - 02/2005
1	Moyamoya Disease (Moya-Moya Disease) 04/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021
1	postintensive care syndrome 12/2021
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2021
1	Siderosis 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Cerebral Hemorrhage 01/2021
1	Hemorrhage 01/2021
1	Partial Epilepsies (Epilepsy, Partial) 10/2020

Drug/Important Bio-Agent (IBA)

31	Amyloid (Amyloid Fibrils)IBA 10/2022 - 11/2007
21	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2003
10	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2020 - 06/2005
9	THK5351IBA 07/2022 - 12/2017
8	Monoamine Oxidase (MAO)IBA 07/2022 - 12/2017
8	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 05/2022 - 03/2010
7	Methionine (L-Methionine)FDA Link 07/2021 - 08/2003
5	Amyloid beta-PeptidesIBA 10/2022 - 11/2007
5	metabotropic glutamate receptor type 1IBA 01/2021 - 08/2015
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2016
5	Dopamine (Intropin)FDA LinkGeneric 09/2015 - 01/2008
4	LigandsIBA 07/2022 - 11/2004
4	Pharmaceutical PreparationsIBA 01/2019 - 11/2004
4	Adenosine A1 ReceptorIBA 01/2018 - 12/2008
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2016 - 04/2014
3	Oxygen (Dioxygen)IBA 04/2022 - 05/2004
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2022 - 12/2018
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021 - 11/2016
3	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2018
3	ApolipoproteinsIBA 01/2021 - 01/2018
3	Insulin (Novolin)FDA Link 01/2019 - 08/2015
3	Levodopa (L Dopa)FDA LinkGeneric 12/2018 - 01/2014
2	SteroidsIBA 12/2021 - 10/2002
2	GadoliniumIBA 07/2021 - 08/2011
2	istradefyllineIBA 01/2021 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 06/2019 - 01/2017
2	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 06/2016 - 08/2015
2	3-Iodobenzylguanidine (Iobenguane)IBA 04/2014 - 01/2012
2	GABA-A Receptors (GABA(A) Receptor)IBA 12/2012 - 05/2003
2	Adenosine (Adenocard)FDA LinkGeneric 02/2011 - 12/2008
2	Amino Acids FDA Link 07/2009 - 04/2005
2	Biological ProductsIBA 06/2009 - 09/2005
2	Deoxyglucose (2 Deoxy D glucose)IBA 04/2008 - 04/2007
2	RacloprideIBA 02/2005 - 12/2002
2	CholesterolIBA 07/2004 - 06/2003
2	OxysterolsIBA 06/2003 - 02/2002
2	ParaquatIBA 06/2003 - 02/2002
1	1-dodecylpyridoxal (PLD)IBA 04/2022
1	AcidsIBA 03/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Coffee FDA Link 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Selegiline (E250)FDA LinkGeneric 01/2021
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2021
1	Presenilin-1IBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2020
1	FluoridesIBA 09/2020
1	tau Proteins (tau Protein)IBA 06/2019
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 06/2019
1	AminopyridinesIBA 06/2019
1	MK-6240IBA 06/2019

Therapy/Procedure

9	Therapeutics 01/2019 - 03/2003
3	Drug Therapy (Chemotherapy) 12/2011 - 09/2005
1	Arthroplasty 09/2020